Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Thymalfasin

EU orphan designation number: EU/3/02/110   
Active ingredient: Thymalfasin
Indication: Treatment of hepatocellular carcinoma
Sponsor: SciClone Pharmaceuticals Italy S.r.l
Via Lisbona 11, 00198 Roma, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2002 Orphan designation EMEA/OD/015/02 (2002)3017 of 30/07/2002